Recommended Dose of Vonoprazan for GERD
For erosive esophagitis (EE), use vonoprazan 20 mg once daily for 8 weeks for healing, then 10 mg once daily for maintenance; for non-erosive reflux disease (NERD), use 10 mg once daily, though vonoprazan should generally not be first-line therapy unless PPIs have failed. 1
Dosing by GERD Subtype
Erosive Esophagitis (LA Grade A/B - Mild)
- Healing phase: 20 mg once daily for 8 weeks 2, 1
- Maintenance phase: 10 mg once daily 2, 1
- Maintenance rates at 24 weeks: 81-82% with vonoprazan 10 mg vs 77% with lansoprazole 15 mg 2
- Important caveat: Vonoprazan should generally NOT be first-line therapy for mild EE due to higher cost and limited long-term safety data 2. Reserve for patients who fail twice-daily PPI therapy with documented acid-related reflux.
Erosive Esophagitis (LA Grade C/D - Severe)
- Healing phase: 20 mg once daily for 8 weeks 1
- Maintenance phase: 10-20 mg once daily 2
- Vonoprazan demonstrates superior maintenance rates in severe EE: 75-77% with vonoprazan (10-20 mg) vs 62% with lansoprazole 15 mg at 24 weeks 2
- Recurrence rates significantly lower: 5-13% with vonoprazan vs 39% with lansoprazole 2
- This is the strongest indication for vonoprazan as first-line therapy 2
Non-Erosive Reflux Disease (NERD)
- Dose: 10 mg once daily 1
- Duration: 4 weeks initially 1
- Evidence shows modest benefit: 45% heartburn-free days with vonoprazan 10 mg vs 28% with placebo 1
- Critical limitation: Vonoprazan should generally NOT be first-line for NERD 2. Use only in selected patients who fail twice-daily PPI therapy with documented acid-related reflux.
- The 20 mg dose shows slightly better efficacy than 10 mg for NERD but is not FDA-approved for this indication 3
Refractory GERD (PPI Failures)
- Initial dose: 20 mg once daily for 4-8 weeks 4
- Maintenance: 10 mg once daily, with option to escalate back to 20 mg if symptoms recur 5
- Approximately 22% of patients on maintenance 10 mg therapy require dose escalation to 20 mg during long-term follow-up 5
- Predictor for dose escalation: Pre-existing epigastric pain significantly predicts need for higher dose (69% vs 88% dose-escalation-free rate at 1 year) 5
Practical Dosing Algorithm
- Confirm GERD severity via endoscopy before initiating vonoprazan
- For LA Grade C/D EE: Start 20 mg daily × 8 weeks → step down to 10 mg for maintenance
- For LA Grade A/B EE: Only use if failed twice-daily PPI; start 20 mg daily × 8 weeks → 10 mg maintenance
- For NERD: Only use if failed twice-daily PPI; start 10 mg daily × 4 weeks
- For refractory symptoms on 10 mg maintenance: Escalate to 20 mg daily, particularly if epigastric pain present
Administration Details
- Timing: Can be taken independent of meals (unlike PPIs) 2
- Food effect: High-fat meals cause minimal changes (5% increase in Cmax, 15% increase in AUC) - not clinically significant 1
- Onset: Steady state achieved by Day 3-4 1
- Step-down approach: For mild RE, consider stepping from 20 mg → 10 mg → discontinuation based on symptom response; 71% successfully step down to 10 mg and 46% discontinue entirely 6
Key Caveats
Cost considerations: Vonoprazan is markedly more expensive than standard and double-dose PPIs in the United States, which limits its role as first-line therapy except in severe EE 2
Not for uninvestigated heartburn: Do not use vonoprazan as empiric therapy without endoscopic confirmation of GERD 2
Renal/hepatic impairment: No dose adjustment needed for mild-moderate renal impairment; use caution in severe hepatic impairment (2.6-fold increase in exposure) 1